MEDIQON Group AG (MDCKF) AI Stock Analysis

MEDIQON Group AG

(Other OTC:MDCKF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong revenue growthRevenue growth at this scale indicates expanding commercial activity and increasing business volume. If sustained, the larger revenue base can support operating leverage, strengthen market presence, and provide a foundation for restoring profitability as execution and cost control improve.

Negative Factors

Severe profitability deteriorationThe sharp move into negative gross profit and substantial operating and net losses shows that revenue growth is not currently translating into earnings. Persistent losses can consume financial resources, weaken reinvestment capacity, and make the business more dependent on successful cost and execution improvements.

MEDIQON Group AG (MDCKF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $1.09B
Dividend Yield: ―
Average Volume (3M): 5,571
Price to Earnings (P/E): -31.3
Beta (1Y): 0.09
Revenue Growth: 75.13%
EPS Growth: -57.58%
Country: US
Employees: 1,300
Sector: Technology
Sector Strength: 61
Industry: Software - Application

MEDIQON Group AG Business Overview & Revenue Model

Company Description

CHAPTERS Group AG, headquartered in Hamburg, Germany, was established in 1998 and rebranded from MEDIQON Group AG in July 2023. The company delivers a broad spectrum of software solutions across the DACH region, catering to numerous industries and ap...

MEDIQON Group AG Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

MDCKF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:OBS	67Neutral	EUR 44.32M	11.70	10.52%	2.14%	0.88%	9.19%
DE:A1OS	63Neutral	EUR 403.54M	-40.30	-8.99%	1.48%	-1.94%	-161.38%
Sector *	61Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
DE:BC8	60Neutral	EUR 4.22B	17.09	12.00%	2.09%	7.74%	14.82%
DE:ADN1	59Neutral	EUR 474.60M	25.60	9.65%	1.07%	12.73%	51.34%

* Technology Sector Average

Performance Comparison

MDCKF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MDCKF	MEDIQON Group AG	51.11	8.27	19.29%
DE:ADN1	adesso AG	72.70	-16.63	-18.62%
DE:A1OS	All For One Group Se	81.00	41.39	104.47%
DE:BC8	Bechtle Aktiengesellschaft	33.50	-1.64	-4.66%
DE:OBS	ORBIS AG	4.68	-1.05	-18.37%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

MEDIQON Group AG AI Stock Analysis